A Medicinal Chemistry Perspective on Anticonvulsant Drug Design: Targets, Mechanisms, and Spiro Compounds
Drug Development Research · 2026
DOI: 10.1002/ddr.70317 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Drug Development Research, 2026. Verfasst von Ghada Abdel Hamid und 3 weiteren Autor:innen. Beteiligte Einrichtung: Pharmaceutical Chemistry Department, Collage of Pharmaceutical Science and Drug Manufacturing, Misr University for Science and Technology, Giza, Egyp…. Hauptthemen laut MEDLINE: Anticonvulsants, Spiro Compounds, Drug Design, Epilepsy. Die Arbeit nennt 103 Literaturangaben.
Abstract (Originalsprache)
The neurological condition known as epilepsy is typified by frequent, unprovoked seizures brought on by aberrant or excessive synchronized neuronal activity in the brain. It can arise from various causes, including brain injury, tumors, infections, immune disorders, or congenital anomalies. However, in many patients, the underlying cause remains unknown. Epileptic seizures are broadly classified into two types: generalized and focal (or partial) seizures. Generalized seizures involve electrical discharges that affect the entire brain, while focal seizures are confined to a specific region. The World Health Organization (WHO) estimates that 50 million individuals worldwide suffer from epilepsy, with low‐ and middle‐income nations accounting for over 80% of cases. In spite of the development of numerous antiepileptic drugs (AEDs), about 30% of individuals with epilepsy suffer from drug‐resistant epilepsy (DRE), where seizures remain uncontrolled by current treatments. As a result, the search for new anticonvulsants with improved efficacy and reduced toxicity is a paramount demand. However, target‐based drug discovery approaches are relatively uncommon due to limited understanding of the molecular pathways involved in epilepsy and the complex mechanisms of action of most existing AEDs. In this review, we investigate the characteristics of anticonvulsant drugs, the classification of epileptic seizures, the mechanisms through which these drugs exert their effects and spiro compounds with anticonvulsant activity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Pharmaceutical Chemistry Department, Collage of Pharmaceutical Science and Drug Manufacturing, Misr University for Science and Technology, Giza, Egypt.
- Postgraduate program in Pharmaceutical Chemistry, Faculty of Pharmacy, Cairo University, Cairo, Egypt.
- Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Cairo University, Cairo, Egypt.
ORCID-Profile: Walaa Hamada Abd-Allah
Zitieren
APA
Hamid, G. A., Elmasry, G. F., El-Moghazy, S. M., & Abd-Allah, W. H. (2026). A Medicinal Chemistry Perspective on Anticonvulsant Drug Design: Targets, Mechanisms, and Spiro Compounds. Drug Development Research. https://doi.org/10.1002/ddr.70317
Vancouver
Hamid GA, Elmasry GF, El-Moghazy SM, Abd-Allah WH. A Medicinal Chemistry Perspective on Anticonvulsant Drug Design: Targets, Mechanisms, and Spiro Compounds. Drug Development Research. 2026. doi:10.1002/ddr.70317
BibTeX
@article{Hamid2026,
author = {Hamid, Ghada Abdel and Elmasry, Ghada F and El-Moghazy, Samir M and Abd-Allah, Walaa Hamada},
title = {A Medicinal Chemistry Perspective on Anticonvulsant Drug Design: Targets, Mechanisms, and Spiro Compounds},
journal = {Drug Development Research},
year = {2026},
doi = {10.1002/ddr.70317}
}
EUVIMED